Inactive Instrument

Acarix AB Share Price Nasdaq Stockholm

Equities

Advanced Medical Equipment & Technology

End-of-day quote Nasdaq Stockholm
- SEK - Intraday chart for Acarix AB

Financials

Sales 2024 * 86.9M 7.96M 664M Sales 2025 * 191M 17.53M 1.46B Capitalization 199M 18.22M 1.52B
Net income 2024 * -24M -2.2M -183M Net income 2025 * 58M 5.31M 443M EV / Sales 2024 * 2.24 x
Net cash position 2024 * 4M 366K 30.58M Net cash position 2025 * - 0 0 EV / Sales 2025 * 1.04 x
P/E ratio 2024 *
-
P/E ratio 2025 *
2.51 x
Employees -
Yield 2024 *
-
Yield 2025 *
-
Free-Float 88.07%
More Fundamentals * Assessed data
Managers TitleAgeSince
Founder 60 01/07/01
Director of Finance/CFO 60 01/16/01
Chief Tech/Sci/R&D Officer 47 01/22/01
Members of the board TitleAgeSince
Chairman 51 11/21/11
Director/Board Member 64 01/14/01
Director/Board Member 70 11/21/11
More insiders
Acarix AB is a Sweden-based provider of diagnostic solutions for coronary artery disease (CAD). The Company’s primary product CADScor System features phonocardiography technique and algorithms. The CADScor System is fixed with a specific patch to the chest of the patient, with the recording head placed at the forth left intercostal space, and the sensor resting on the sternum. Instructions for the procedure are given on the display for the operator and audio cues guide a patient during the two-minute heart sound recording. After recording, the CAD-score is calculated, and presented on the display of the CADScor Sensor, enabling a physicians, nurses and laboratory technicians to make a rule-out diagnosis.
Calendar
More about the company